Diagnostic viewer is designed to give providers personalized anywhere, anytime access to medical imaging.
Ambra Health has released Ambra ProViewer, its next generation cloud-based diagnostic viewer that is designed to give providers anywhere, anytime access to images.
By pairing its U.S. Food & Drug Administration-cleared ProViewer with a cloud PACS system, this tool is designed to give providers personalized mobile access to manage diagnostic images and supplemental photos and videos. It also offers full diagnostic, read-at-home, and teleradiology capabilities.
Courtesy: Ambra Health
According to a company statement, the ProViewer offers three key features:
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.